Link Pharma Chem Fair Value
Link Pharma Chem (LINKPH) average fair value is ₹79.27 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹28.54 (+177.76%), fair value range ₹32.5–₹157.55. For live price and a broader fundamental view, visit LINKPH stock live price.
Fair Value Analysis Export
LINKPH Fair Value vs Current Price — Valuation Summary
LINKPH average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. Explore Link Pharma Chem intrinsic worth to estimate fundamental worth using multiple valuation models.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
LINKPH Fair Value Analysis — Data Sources & Coverage
Link Pharma Chem financial data sources, valuation methods applied and sector benchmarks used. Analyse LINKPH promoter holding to track promoter, FII and institutional holdings.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
LINKPH vs Chemicals Sector Peers — P/E, P/B & Market Cap
Link Pharma Chem P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Polychem | POLYCHEM | - | 1.8 | ₹86 |
| Kanchi Karpooram | KANCHI | 29.19 | 0.7 | ₹148 |
| Blue Pearl Agriventures | BPAGRI | 2564.0 | 25.33 | ₹1,622 |
| Omkar Pharmachem | OMKARPH | 157.39 | 3.03 | ₹29 |
| Beezaasan Explotech | BEEZAASAN | 20.83 | 1.94 | ₹309 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.